Martin E. Evans

3.9k total citations
96 papers, 3.0k citations indexed

About

Martin E. Evans is a scholar working on Infectious Diseases, Epidemiology and Applied Microbiology and Biotechnology. According to data from OpenAlex, Martin E. Evans has authored 96 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Infectious Diseases, 30 papers in Epidemiology and 22 papers in Applied Microbiology and Biotechnology. Recurrent topics in Martin E. Evans's work include Antimicrobial Resistance in Staphylococcus (32 papers), Clostridium difficile and Clostridium perfringens research (24 papers) and Antibiotic Use and Resistance (22 papers). Martin E. Evans is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (32 papers), Clostridium difficile and Clostridium perfringens research (24 papers) and Antibiotic Use and Resistance (22 papers). Martin E. Evans collaborates with scholars based in United States, Australia and Uganda. Martin E. Evans's co-authors include Robert P. Rapp, David J. Feola, William Schaffner, D. W. Gregory, Z. A. McGee, Gary A. Roselle, Stephen M. Kralovic, Loretta A. Simbartl, Rajiv Jain and Matthew Pollack and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Martin E. Evans

91 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martin E. Evans United States	27	1.1k	779	707	674	582	96	3.0k
Tara N. Palmore United States	31	1.0k 0.9×	1.1k 1.5×	1.4k 1.9×	816 1.2×	394 0.7×	79	4.0k
Achilleas Gikas Greece	31	1.1k 0.9×	737 0.9×	857 1.2×	351 0.5×	298 0.5×	112	3.0k
Susan Whittier United States	41	1.9k 1.6×	1.5k 2.0×	973 1.4×	820 1.2×	342 0.6×	118	4.7k
Alicia Hidrón United States	14	1.9k 1.7×	1.2k 1.5×	1.2k 1.7×	809 1.2×	423 0.7×	31	4.1k
Laurence Armand-Lefèvre France	29	1.2k 1.0×	898 1.2×	1.2k 1.7×	688 1.0×	335 0.6×	112	3.0k
José L. Pérez Spain	24	695 0.6×	1.1k 1.4×	524 0.7×	628 0.9×	397 0.7×	91	3.0k
Francesco Menichetti Italy	37	1.6k 1.4×	1.7k 2.2×	1.5k 2.1×	333 0.5×	1.0k 1.7×	111	4.2k
Joseph F. John United States	31	1.9k 1.7×	977 1.3×	774 1.1×	1.0k 1.5×	450 0.8×	93	4.9k
Gordon M. Trenholme United States	32	1.4k 1.2×	1.4k 1.8×	1.4k 2.0×	359 0.5×	677 1.2×	117	4.6k
Étienne Ruppé France	29	807 0.7×	722 0.9×	1.3k 1.8×	698 1.0×	352 0.6×	63	2.7k

Countries citing papers authored by Martin E. Evans

Since Specialization

Citations

This map shows the geographic impact of Martin E. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin E. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin E. Evans more than expected).

Fields of papers citing papers by Martin E. Evans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin E. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin E. Evans. The network helps show where Martin E. Evans may publish in the future.

Co-authorship network of co-authors of Martin E. Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Martin E. Evans. A scholar is included among the top collaborators of Martin E. Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin E. Evans. Martin E. Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smith, Matthew, Christopher J. Crnich, Curtis J. Donskey, et al.. (2024). Research agenda for transmission prevention within the Veterans Health Administration, 2024–2028. Infection Control and Hospital Epidemiology. 45(8). 913–922. 1 indexed citations

Pfeiffer, Christopher D., Makoto Jones, J. Stacey Klutts, et al.. (2024). Development and implementation of a nationwide multidrug-resistant organism tracking and alert system for Veterans Affairs medical centers. Infection Control and Hospital Epidemiology. 45(9). 1073–1078. 2 indexed citations

Evans, Martin E., Loretta A. Simbartl, Makoto Jones, et al.. (2023). Active Surveillance and Contact Precautions for Preventing Methicillin-Resistant Staphylococcus aureus Healthcare-Associated Infections During the COVID-19 Pandemic. Clinical Infectious Diseases. 77(10). 1381–1386. 12 indexed citations

Fitzpatrick, Margaret A., Katie J. Suda, Geneva Wilson, et al.. (2023). Treatment effectiveness of antibiotic therapy in Veterans with multidrug-resistant Acinetobacter spp. bacteremia. SHILAP Revista de lepidopterología. 3(1). e230–e230.

Evans, Martin E., Loretta A. Simbartl, Stephen M. Kralovic, et al.. (2022). Healthcare-associated infections in Veterans Affairs acute-care and long-term healthcare facilities during the coronavirus disease 2019 (COVID-19) pandemic. Infection Control and Hospital Epidemiology. 44(3). 420–426. 21 indexed citations

Gamage, Shantini D., Martin E. Evans, Karen Lipscomb, et al.. (2022). Hospital coronavirus disease 2019 (COVID-19) public health reporting: Lessons from validation of an automated surveillance tool to facilitate data collection. Infection Control and Hospital Epidemiology. 44(5). 802–804. 1 indexed citations

Evans, Martin E., et al.. (2022). Lack of correlation between standardized antimicrobial administration ratios (SAARs) and healthcare-facility–onset Clostridioides difficile infection rates in Veterans Affairs medical facilities. Infection Control and Hospital Epidemiology. 44(6). 945–947. 3 indexed citations

Fitzpatrick, Margaret A., Katie J. Suda, Linda Poggensee, et al.. (2022). Treatment of extensively-drug resistant (XDR) Acinetobacter and impact on clinical outcomes in U.S. veterans affairs (VA) medical centers. American Journal of Infection Control. 50(9). 1020–1025. 3 indexed citations

Fitzpatrick, Margaret A., Katie J. Suda, Swetha Ramanathan, et al.. (2022). Increased carbapenemase testing following implementation of national VA guidelines for carbapenem-resistant Enterobacterales (CRE). SHILAP Revista de lepidopterología. 2(1). e88–e88. 3 indexed citations

10.

Evans, Martin E., et al.. (2021). Association between Clostridioides difficile infection testing results and decision to treat. Infection Control and Hospital Epidemiology. 43(12). 1940–1941. 2 indexed citations

11.

Evans, Martin E., et al.. (2021). Implementing a postdischarge methicillin-resistant Staphylococcus aureus decolonization protocol within a Veterans Affairs Health Care System facility. Infection Control and Hospital Epidemiology. 43(9). 1276–1277.

12.

Roselle, Gary A., et al.. (2020). A targeted assessment for prevention strategy to decrease Clostridioides difficile infections in Veterans Affairs acute-care medical centers. Infection Control and Hospital Epidemiology. 41(3). 302–305. 3 indexed citations

13.

Evans, Martin E., et al.. (2018). Evaluating the Effect of a Clostridium difficile Infection Prevention Initiative in Veterans Health Administration Long-Term Care Facilities. Infection Control and Hospital Epidemiology. 39(3). 343–345. 6 indexed citations

14.

Evans, Martin E., Stephen M. Kralovic, Loretta A. Simbartl, Rajiv Jain, & Gary A. Roselle. (2016). Effect of a Clostridium difficile Infection Prevention Initiative in Veterans Affairs Acute Care Facilities. Infection Control and Hospital Epidemiology. 37(6). 720–722. 35 indexed citations

15.

Evans, Martin E., et al.. (2015). Blastomyces dermatitidis and the Adult Respiratory Distress Syndrome. American Review of Respiratory Disease.

16.

Strymish, Judith, et al.. (2014). Survival Time of Methicillin-Resistant Staphylococcus aureus–Free Status after Institutional Clearance. Infection Control and Hospital Epidemiology. 35(10). 1271–1276. 2 indexed citations

17.

Evans, Martin E., Loretta A. Simbartl, Stephen M. Kralovic, Rajiv Jain, & Gary A. Roselle. (2014). Clostridium difficile Infections in Veterans Health Administration Acute Care Facilities. Infection Control and Hospital Epidemiology. 35(8). 1037–1042. 44 indexed citations

18.

Voils, Stacy A., Martin E. Evans, Matthew Lane, Robert H. Schosser, & Robert P. Rapp. (2004). Use of Macrolides and Tetracyclines for Chronic Inflammatory Diseases. Annals of Pharmacotherapy. 39(1). 86–94. 43 indexed citations

19.

Rapp, Robert P., Julie A. Ribes, Sue B. Overman, Theodore Darkow, & Martin E. Evans. (2002). A Decade of Antimicrobial Susceptibilities at the University of Kentucky Hospital. Annals of Pharmacotherapy. 36(4). 596–604. 4 indexed citations

20.

Evans, Martin E. & Judith A. Lesnaw. (1999). Infection Control in Gene Therapy. Infection Control and Hospital Epidemiology. 20(8). 568–576. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact